Le Lézard
Classified in: Health
Subjects: CHI, LGB, DEI

Children's Healthcare Canada and the Pediatric Chairs of Canada Support Access to Healthcare for Transgender and Gender-Diverse Youth


OTTAWA, ON, Feb. 1, 2024 /CNW/ - Children's Healthcare Canada and the Pediatric Chairs of Canada are dedicated to accelerating excellence in health systems serving children, youth and families, and that includes providing evidence-based gender-affirming care for transgender or gender-diverse youth. All care decisions must be made privately between individuals and their healthcare provider.

Gender identity, a critical facet of a young person's sense of self, first emerges in early childhood and evolves throughout childhood and adolescence [1]. Gender diversity must be respected as an expression of human diversity, and children and youth who seek gender-affirming care are entitled to receive timely access to healthcare that supports their development journey. Gender-affirming care can take multiple forms and is defined as care provided to an individual to support their gender identity; this care may be social, psychological or medical.

Our member organizations are dedicated to delivering highly specialized, individualized care for children and youth, and maintaining confidential relationships between all patients and their healthcare providers. They are focused on ensuring that every child, youth and family receives highly tailored, comprehensive and evidence-based services. Services for youth accessing gender-affirming care are no different.

All children and youth deserve acceptance, understanding and supportive care. Children's Healthcare Canada and the Pediatric Chairs of Canada remain steadfast advocates for Canada's youth, including those who are transgender and gender diverse.

SOURCE Children's Healthcare Canada


These press releases may also interest you

at 21:03
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been selected for...

at 21:00
Bristol Myers Squibb today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment...

at 20:54
Starlight Children's Foundation CEO, Adam Garone, has been named Nonprofit Executive of the Year (Large), by the Los Angeles Business Journal. The prestigious award was presented at the annual Nonprofit and Corporate Citizenship Award luncheon held...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced the completion of patient enrollment for the phase II clinical trial of ICP-488, a TYK2...

at 19:56
Rare Cannabinoid Company is proud to announce the launch of its new,...

at 18:58
Children's HealthSM and UT Southwestern Medical Center announced a historic gift of $100 million from the Jean and Mack Pogue family in support of the $5 billion new Dallas pediatric campus, unveiled earlier this year. The gift from the Pogue...



News published on and distributed by: